既往夹闭颅内动脉瘤的血管内再治疗:个体患者数据Meta分析
该系统评价与个体患者数据Meta分析纳入26项研究、413例患者共414个既往夹闭的颅内动脉瘤,评估血管内再治疗的有效性与安全性。结果显示末次随访良好功能结局比例为77.3%(95%CI: 72.15; 81.74),完全闭塞率为74.4%(95%CI: 64.38; 82.29)。夹闭至再治疗间隔超过1个月与良好功能结局相关(OR 7.37,95%CI: 2.16; 29.94),后循环动脉瘤与围手术期并发症相关(OR 8.05,95%CI: 1.45; 50.48)。
要点
- 既往夹闭动脉瘤血管内再治疗在严格筛选患者中安全有效,完全闭塞率74.4%。
- 夹闭至再治疗间隔超过1个月与良好功能结局相关(OR 7.37)。
- 后循环动脉瘤围手术期并发症风险更高(OR 8.05),需谨慎评估。
核心结论
- 对既往夹闭的颅内动脉瘤行血管内再治疗在严格筛选的患者中可安全有效地完成。
- 再治疗指征需与既往夹闭动脉瘤的自然病史仔细权衡。
研究设计与样本
- 系统检索Medline、Embase和Cochrane Central数据库。
- 纳入26项研究,共413例患者、414个既往夹闭后行血管内再治疗的颅内动脉瘤。
- 采用单阶段个体患者数据Meta分析,以广义线性混合模型校正预设协变量,并将研究作为随机效应。
主要发现
- 再治疗方式中单纯弹簧圈栓塞249个(60.1%)、球囊辅助栓塞39个(9.4%)、支架辅助栓塞39个(9.4%)、血流导向装置81个(19.6%)、离断6个(1.4%)。
- 动脉瘤位置前循环88.6%、后循环11.4%;再治疗时平均大小为6.8 mm。
- 再治疗时70.4%的既往夹闭动脉瘤为未破裂,已报告原因主要为再生(n=48)、残留(n=49)或复发(n=41)。
- 临床随访26.8个月,良好功能结局比例为77.3%(95%CI: 72.15; 81.74),神经功能改善/不变比例为88.2%(95%CI: 64.57; 96.85),死亡比例为6.9%(95%CI: 4.19; 11.18)。
- 血管造影随访19.4个月,完全闭塞比例为74.4%(95%CI: 64.38; 82.29)。
关键数值与推荐
- 夹闭至血管内再治疗间隔超过1个月与良好功能结局相关(OR 7.37,95%CI: 2.16; 29.94)。
- 后循环动脉瘤与围手术期并发症相关(OR 8.05,95%CI: 1.45; 50.48)。
临床怎么用
- 对既往夹闭动脉瘤出现再生、残留或复发且适合血管内治疗的患者,可考虑血管内再治疗。
- 后循环动脉瘤再治疗时需更谨慎评估围手术期并发症风险。
- 再治疗决策应结合既往夹闭动脉瘤的自然病史与患者个体情况综合权衡。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: To evaluate the effectiveness and safety of endovascular retreatment of previously clipped intracranial aneurysms (IAs). METHODS: Systematic searches of Medline, Embase and Cochrane Central were performed. The primary outcome was good functional outcome (modified Rankin Scale 0-2) at the last follow-up. Secondary outcomes included complete occlusion, and perioperative complications. One-stage individual patient data meta-analysis was performed, adjusted using generalized linear mixed models with prespecified covariables and study as a random effect. RESULTS: Twenty-six studies reporting 413 patients with 414 previously clipped IAs retreated endovascularly were included. Totally, 249 (60.1%), 39 (9.4%), 39 (9.4%), 81 (19.6%) and 6 (1.4%), underwent simple coiling, balloon-assisted coiling, stent-assisted coiling, flow diversion, and disruption, respectively. Of these, 88.6% and 11.4% IAs were located anteriorly and posteriorly. Mean size of the IAs at retreatment was 6.8 mm. Most (70.4%) of previously clipped IAs were unruptured at retreatment, mainly due to regrowth (n = 48), remnants (n = 49) or recurrences (n = 41), when reported. With clinical follow-up of 26.8 months, proportions of good functional outcomes, improved/unchanged neurological outcomes, and deaths were 77.3% (95%CI: 72.15; 81.74), 88.2% (95%CI: 64.57; 96.85), and 6.9% (95%CI: 4.19; 11.18), respectively. With angiographical follow-up of 19.4 months, the proportion of complete occlusion was 74.4% (95%CI: 64.38; 82.29). Multivariate analyses showed that a prolonged interval (>1 month) between clipping and endovascular retreatment was associated with good functional outcome (odds ratio 7.37, 95%CI: 2.16; 29.94) whereas posteriorly located IAs were associated with perioperative complications (odds ratio 8.05, 95%CI: 1.45; 50.48). CONCLUSION: Endovascular retreatment of previously clipped IAs can be accomplished safely and effectively in well-selected patients. The indications for retreatment need to be carefully weighed against the natural history of a previously clipped IA.
引用
- Lee KS, Han J, Kirollos SRW, et al. Endovascular Retreatment of Previously Clipped Intracranial Aneurysms: An Individual Patient Data Meta-analysis. Neurosurgery. 2025. PMID: 40891857. doi:10.1227/neu.0000000000003693
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。